Article

New editor at IOVS

David Beebe, PhD, FARVO, has been elected as the editor-in-chief of Investigative Ophthalmology & Visual Science (IOVS), the journal of the Association for Research in Vision and Ophthalmology (ARVO).

Rockville, MD-David Beebe, PhD, FARVO, has been elected as the editor-in-chief of Investigative Ophthalmology & Visual Science (IOVS), the journal of the Association for Research in Vision and Ophthalmology (ARVO).

Beebe was elected by ARVO’s members to replace current IOVS editor-in-chief Paul L. Kaufman, MD. Beebe’s 5-year term will begin in January 2013, and he will serve as editor-in-chief for 5 years. A former ARVO Trustee, Beebe served as the association’s president from 2000 to 2001.

Beebe is the Janet and Bernard Becker professor of ophthalmology and visual sciences at Washington University in St. Louis, MO. From 1998 to 2007, he served as an editorial board member of IOVS, and currently is an associate editor of the journal, managing manuscripts dealing with lens and cataract, eye development, cell biology, and all genetic studies of eye diseases. Beebe was also a member of the editorial board of Experimental Eye Research for 6 years.

The journal is online only (www.iovs.org) and articles are published daily.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.